发明名称 |
Platelet aggregation inhibition using low molecular weight heparin in combination with a GP IIb/IIIa antagonist |
摘要 |
A method for inhibiting platelet aggregation in a mammal comprising administering to the mammal a safe and therapeutically effective amount of a GPIIb/IIIa receptor antagonist or a pharmaceutically acceptable salt thereof and a safe and therapeutically effective amount of low molecular weight heparin. A method for inhibiting platelet aggregation in a mammal comprising administering to the mammal a safe and therapeutically effective amount of (2-S-(n-butylsulfonylamino)-3[4-(piperidin-4-yl)butyloxyphenyl]-propionic acid or a pharmaceutically acceptable salt thereof and a safe and therapeutically effective amount of low molecular weight heparin.
|
申请公布号 |
US6136794(A) |
申请公布日期 |
2000.10.24 |
申请号 |
US19990240429 |
申请日期 |
1999.01.29 |
申请人 |
MERCK & CO., INC. |
发明人 |
COOK, JACQUELYNN J.;GOULD, ROBERT J.;SAX, FREDERIC L. |
分类号 |
A61K45/06;(IPC1-7):A61K31/725 |
主分类号 |
A61K45/06 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|